Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Nuclear Medicine

Free Subscription Articles published in Neurology Retrieve available abstracts of 91 articles: HTML format

Single Articles

May 2024
1. RUS T, Cuderman A, Georgiev D
   Parkinsonism Associated With Traumatic Hemorrhage in Substantia Nigra: Role of Presynaptic Dopaminergic Imaging.
   Neurology. 2024;102:e209384.
   PubMed    
   
   
   April 2024
2. WEINSTEIN G, Kojis DJ, Ghosh S, Beiser AS, et al
   Association of Neurotrophic Factors at Midlife With In Vivo Measures of beta-Amyloid and Tau Burden 15 Years Later in Dementia-Free Adults.
   Neurology. 2024;102:e209198.
   PubMed     Abstract available
   
   
   
3. CAI Y, Shi D, Lan G, Chen L, et al
   Association of beta-Amyloid, Microglial Activation, Cortical Thickness, and Metabolism in Older Adults Without Dementia.
   Neurology. 2024;102:e209205.
   PubMed     Abstract available
   
   
   March 2024
4. HONIG M, Altomare D, Caprioglio C, Collij L, et al
   Association Between Years of Education and Amyloid Burden in Patients With Subjective Cognitive Decline, MCI, and Alzheimer Disease.
   Neurology. 2024;102:e208053.
   PubMed     Abstract available
   
   
   
5. ACKLEY S, Calmasini C, Bouteloup V, Hill-Jarrett TG, et al
   Contribution of Global Amyloid-PET Imaging for Predicting Future Cognition in the MEMENTO Cohort.
   Neurology. 2024;102:e208054.
   PubMed     Abstract available
   
   
   February 2024
6. RAHAYEL S, Postuma R, Baril AA, Misic B, et al
   (99m)Tc-HMPAO SPECT Perfusion Signatures Associated With Clinical Progression in Patients With Isolated REM Sleep Behavior Disorder.
   Neurology. 2024;102:e208015.
   PubMed     Abstract available
   
   
   January 2024
7. PALLEIS C, Franzmeier N, Weidinger E, Bernhardt AM, et al
   Association of Neurofilament Light Chain, [(18)F]PI-2620 Tau-PET, TSPO-PET, and Clinical Progression in Patients With beta-Amyloid-Negative CBS.
   Neurology. 2024;102:e207901.
   PubMed     Abstract available
   
   
   December 2023
8. HANSEEUW BJ, Jacobs HIL, Schultz AP, Buckley RF, et al
   Association of Pathologic and Volumetric Biomarker Changes With Cognitive Decline in Clinically Normal Adults.
   Neurology. 2023;101:e2533-e2544.
   PubMed     Abstract available
   
   
   November 2023
9. YOON SH, Kim HK, Lee JH, Chun JH, et al
   Association of Sleep Disturbances With Brain Amyloid and Tau Burden, Cortical Atrophy, and Cognitive Dysfunction Across the AD Continuum.
   Neurology. 2023;101:e2162-e2171.
   PubMed     Abstract available
   
   
   October 2023
10. THEIS H, Bischof GN, Bruggemann N, Dargvainiene J, et al
    In Vivo Measurement of Tau Depositions in Anti-IgLON5 Disease Using (18)F-PI-2620 PET.
    Neurology. 2023 Oct 25:10.1212/WNL.0000000000207870.
    PubMed     Abstract available
    
    
    
11. BEAUCHAMP LC, Dore V, Villemagne VL, Xu S, et al
    Utilizing (18)F-AV-133 VMAT2 PET Imaging to Monitor Progressive Nigrostriatal Degeneration in Parkinson Disease.
    Neurology. 2023 Oct 10:10.1212/WNL.0000000000207748.
    PubMed     Abstract available
    
    
    September 2023
12. COOMANS EM, de Koning LA, Rikken RM, Verfaillie SC, et al
    Performance of a [(18)F]Flortaucipir PET Visual Read Method Across the Alzheimer Disease Continuum and in Dementia With Lewy Bodies.
    Neurology. 2023 Sep 25:10.1212/WNL.0000000000207794.
    PubMed     Abstract available
    
    
    
13. CHEVAL M, Rodrigo S, Leroy C, Taussig D, et al
    [(18)F]DPA-714 PET Imaging in the Presurgical Evaluation of Patients With Drug-Resistant Focal Epilepsy.
    Neurology. 2023 Sep 25:10.1212/WNL.0000000000207811.
    PubMed     Abstract available
    
    
    
14. MALPETTI M, Rabinovici GD
    From Clinical Trials to Memory Clinics, tau-PET Visual Reads Can Help Diagnosis and Patient Stratification.
    Neurology. 2023 Sep 25:10.1212/WNL.0000000000207935.
    PubMed    
    
    
    August 2023
15. SELVARAJAN JMP, Epari S, Sahu A, Dasgupta A, et al
    Pearls & Oy-sters: Primary Diffuse Leptomeningeal Melanocytosis: A Diagnostic Conundrum.
    Neurology. 2023;101:e576-e580.
    PubMed     Abstract available
    
    
    July 2023
16. DURCAN R, Roberts G, Hamilton CA, Donaghy PC, et al
    Serial Nigrostriatal Dopaminergic Imaging in Mild Cognitive Impairment With Lewy Bodies, Alzheimer Disease, and Age-Matched Controls.
    Neurology. 2023 Jul 31:10.1212/WNL.0000000000207621.
    PubMed     Abstract available
    
    
    
17. ANDRE C, Kuhn E, Rehel S, Ourry V, et al
    Association of Sleep-Disordered Breathing and Medial Temporal Lobe Atrophy in Cognitively Unimpaired Amyloid-Positive Older Adults.
    Neurology. 2023;101:e370-e385.
    PubMed     Abstract available
    
    
    
18. PROKOPIOU PC, Engels-Dominguez N, Schultz AP, Sepulcre J, et al
    Association of Novelty-Related Locus Coeruleus Function With Entorhinal Tau Deposition and Memory Decline in Preclinical Alzheimer Disease.
    Neurology. 2023 Jul 25:10.1212/WNL.0000000000207646.
    PubMed     Abstract available
    
    
    
19. QUINN C, Moulton K, Farwell M, Le W, et al
    Imaging With PET/CT of Diffuse CD8 T Cell Infiltration of Skeletal Muscle in Patients with Inclusion Body Myositis.
    Neurology. 2023 Jul 24:10.1212/WNL.0000000000207596.
    PubMed     Abstract available
    
    
    
20. LICHTER DG, Hershey L
    Proposal to Add FDG-PET as an Outcome Measure for Clinical Trials in Patients With Prodromal Lewy Body Dementia.
    Neurology. 2023 Jul 3:10.1212/WNL.0000000000207498.
    PubMed    
    
    
    May 2023
21. DIAZ-GALVAN P, Przybelski SA, Lesnick TG, Schwarz CG, et al
    beta-Amyloid Load on PET Along the Continuum of Dementia With Lewy Bodies.
    Neurology. 2023 May 18:10.1212/WNL.0000000000207393.
    PubMed     Abstract available
    
    
    
22. LUO J, Ma Y, Agboola FJ, Grant E, et al
    Longitudinal Relationships of White Matter Hyperintensities and Alzheimer Disease Biomarkers Across the Adult Lifespan.
    Neurology. 2023 May 18:10.1212/WNL.0000000000207378.
    PubMed     Abstract available
    
    
    
23. CLARKE AJ, Manser D, Fleischer GradDipGC R, Fulham M, et al
    Pearls and Oy-sters: Huntington Disease Presenting as Primary Progressive Aphasia: A Case of Semantics.
    Neurology. 2023 May 18:10.1212/WNL.0000000000207428.
    PubMed     Abstract available
    
    
    
24. DU J, Li A, Shi D, Chen X, et al
    Association of APOE4, Osteoarthritis, beta-Amyloid, and Tau Accumulation in Primary Motor and Somatosensory Regions in Alzheimer Disease.
    Neurology. 2023 May 15:10.1212/WNL.0000000000207369.
    PubMed     Abstract available
    
    
    April 2023
25. LEWIS A, Galetta S
    Editors' Note: Hyperacute Perfusion Imaging Before Pediatric Thrombectomy: Analysis of the Save ChildS Study.
    Neurology. 2023;100:842.
    PubMed    
    
    
    
26. SIEGLER JE, Nguyen TN
    Reader Response: Hyperacute Perfusion Imaging Before Pediatric Thrombectomy: Analysis of the Save ChildS Study.
    Neurology. 2023;100:842-843.
    PubMed    
    
    
    
27. LEE S
    Author Response: Hyperacute Perfusion Imaging Before Pediatric Thrombectomy: Analysis of the Save ChildS Study.
    Neurology. 2023;100:843.
    PubMed    
    
    
    
28. KUHN E, Perrotin A, La Joie R, Touron E, et al
    Association of the Informant-Reported Memory Decline With Cognitive and Brain Deterioration Through the Alzheimer Clinical Continuum.
    Neurology. 2023 Apr 21:10.1212/WNL.0000000000207338.
    PubMed     Abstract available
    
    
    
29. INSEL PS, Kumar A, Hansson O, Mattsson-Carlgren N, et al
    Genetic Moderation of the Association of beta-Amyloid With Cognition and MRI in Alzheimer Disease.
    Neurology. 2023 Apr 21:10.1212/WNL.0000000000207305.
    PubMed     Abstract available
    
    
    
30. TIAN J, Raghavan Pillai SK, Reid RI, Przybelski SA, et al
    White Matter Degeneration Pathways Associated With Tau Deposition in Alzheimer Disease.
    Neurology. 2023 Apr 17:10.1212/WNL.0000000000207250.
    PubMed     Abstract available
    
    
    March 2023
31. KATSANOS AH, Catanese L, Shoamanesh A
    To Use Perfusion Imaging or Not in Patient Selection for Late Time-Window Endovascular Thrombectomy? That Is the Question.
    Neurology. 2023 Mar 29:10.1212/WNL.0000000000207357.
    PubMed    
    
    
    February 2023
32. FERREIRA D, Przybelski SA, Lesnick TG, Schwarz CG, et al
    Cross-sectional Associations of beta-Amyloid, Tau, and Cerebrovascular Biomarkers With Neurodegeneration in Probable Dementia With Lewy Bodies.
    Neurology. 2023;100:e846-e859.
    PubMed     Abstract available
    
    
    January 2023
33. OHRFELT A, Benedet AL, Ashton NJ, Kvartsberg H, et al
    Association of CSF GAP-43 With the Rate of Cognitive Decline and Progression to Dementia in Amyloid-Positive Individuals.
    Neurology. 2023;100:e275-e285.
    PubMed     Abstract available
    
    
    December 2022
34. LEE S, Mlynash M, Christensen S, Jiang B, et al
    Hyperacute Perfusion Imaging Before Pediatric Thrombectomy: Analysis of the Save ChildS Study.
    Neurology. 2022 Dec 21:10.1212/WNL.0000000000201687.
    PubMed     Abstract available
    
    
    
35. DLAMINI N, Stence N
    Hyperacute Perfusion Imaging Before Pediatric Thrombectomy: One step closer.
    Neurology. 2022 Dec 21:10.1212/WNL.0000000000206819.
    PubMed    
    
    
    October 2022
36. MICHIELS L, Thijs L, Mertens N, Sunaert S, et al
    In Vivo Detection of Neurofibrillary Tangles by 18F-MK-6240 PET/MR in Patients With Ischemic Stroke.
    Neurology. 2022 Oct 27. pii: WNL.0000000000201344.
    PubMed     Abstract available
    
    
    
37. QUISPIALAYA KM, Therriault J, Aliaga A, Zimmermann M, et al
    Discordance and Concordance Between Cerebrospinal and [18F]FDG-PET Biomarkers in Assessing Atypical and Early-Onset AD Dementia Cases.
    Neurology. 2022 Oct 20. pii: WNL.0000000000201198.
    PubMed     Abstract available
    
    
    
38. TAJFIROUZ D, Chen JJ, Bhatti MT
    Clinical Reasoning: An 80-Year-Old Woman With a Homonymous Hemianopsia.
    Neurology. 2022;99:713-717.
    PubMed     Abstract available
    
    
    
39. SARRAJ A, Campbell BCV, Pujara D, Albers GW, et al
    Author Response: Accuracy of CT Perfusion-Based Core Estimation of Follow-up Infarction: Effects of Time Since Last Known Well.
    Neurology. 2022;99:633.
    PubMed    
    
    
    
40. GARCIA-TORNEL GARCIA-CAMBA A, Ribo M
    Reader Response: Accuracy of CT Perfusion-Based Core Estimation of Follow-up Infarction: Effects of Time Since Last Known Well.
    Neurology. 2022;99:632-633.
    PubMed    
    
    
    
41. CHUNG SJ, Kim YJ, Kim YJ, Lee HS, et al
    Association Between White Matter Networks and the Pattern of Striatal Dopamine Depletion in Patients With Parkinson Disease.
    Neurology. 2022 Oct 4. pii: WNL.0000000000201269.
    PubMed     Abstract available
    
    
    September 2022
42. SHIMOHAMA S, Tezuka T, Keisuke T, Bun S, et al
    Impact of Amyloid and Tau PET on Changes in Diagnosis and Patient Management.
    Neurology. 2022 Sep 29. pii: WNL.0000000000201389.
    PubMed     Abstract available
    
    
    
43. DEMNITZ-KING H, Gonneaud J, Klimecki OM, Chocat A, et al
    Association of Self-reflection With Cognition and Brain Health in Cognitively Unimpaired Older Adults.
    Neurology. 2022;99:e1422-e1431.
    PubMed     Abstract available
    
    
    
44. KARALIJA N, Johansson J, Papenberg G, Wahlin A, et al
    Longitudinal Dopamine D2 Receptor Changes and Cerebrovascular Health in Aging.
    Neurology. 2022;99:e1278-e1289.
    PubMed     Abstract available
    
    
    
45. KAMAGATA K, Andica C, Takabayashi K, Saito Y, et al
    Association of MRI Indices of Glymphatic System With Amyloid Deposition and Cognition in Mild Cognitive Impairment and Alzheimer Disease.
    Neurology. 2022 Sep 19. pii: WNL.0000000000201300.
    PubMed     Abstract available
    
    
    
46. YEN K, Yaworski A, Bussiere M, Ba F, et al
    Pearls & Oy-sters: A Case Report of Holmes Tremor Due to Nigrostriatal Dopamine Disruption That Responded to Dopamine Replacement Therapy.
    Neurology. 2022;99:480-483.
    PubMed     Abstract available
    
    
    August 2022
47. SEIBYL JP, Kuo P
    What Is the Role of Dopamine Transporter Imaging in Parkinson Prevention Clinical Trials?
    Neurology. 2022;99.
    PubMed    
    
    
    
48. DUMURGIER J, Sabia S, Zetterberg H, Teunissen CE, et al
    A Pragmatic, Data-Driven Method to Determine Cutoffs for CSF Biomarkers of Alzheimer Disease Based on Validation Against PET Imaging.
    Neurology. 2022;99:e669-e678.
    PubMed     Abstract available
    
    
    
49. AKINCI M, Pena-Gomez C, Operto G, Fuentes-Julian S, et al
    Pre-pandemic Alzheimer Disease Biomarkers and Anxious-Depressive Symptoms During the COVID-19 Confinement in Cognitively Unimpaired Adults.
    Neurology. 2022 Aug 2. pii: WNL.0000000000200948.
    PubMed     Abstract available
    
    
    July 2022
50. KEUSS SE, Coath W, Nicholas JM, Poole T, et al
    Associations of beta-Amyloid and Vascular Burden With Rates of Neurodegeneration in Cognitively Normal Members of the 1946 British Birth Cohort.
    Neurology. 2022;99:e129-e141.
    PubMed     Abstract available
    
    
    June 2022
51. PETERSEN KK, Lipton RB, Grober E, Davatzikos C, et al
    Predicting Amyloid Positivity in Cognitively Unimpaired Older Adults: A Machine Learning Approach Using A4 Data.
    Neurology. 2022;98:e2425-e2435.
    PubMed     Abstract available
    
    
    May 2022
52. DUMURGIER J, Sabia S, Zetterberg H, Teunissen C, et al
    Pragmatic, Data-Driven Method to Determine Cutoffs for CSF Biomarkers of Alzheimer Disease Based on Validation Against PET Imaging.
    Neurology. 2022 May 26. pii: WNL.0000000000200735.
    PubMed     Abstract available
    
    
    
53. ASKEN BM, Tanner JA, VandeVrede L, Mantyh WG, et al
    Plasma P-tau181 and P-tau217 in Patients With Traumatic Encephalopathy Syndrome With and Without Evidence of Alzheimer Disease Pathology.
    Neurology. 2022 May 16. pii: WNL.0000000000200678.
    PubMed     Abstract available
    
    
    April 2022
54. COLLIJ LE, Salvado G, Wottschel V, Mastenbroek SE, et al
    Spatial-Temporal Patterns of beta-Amyloid Accumulation: A Subtype and Stage Inference Model Analysis.
    Neurology. 2022;98:e1692-e1703.
    PubMed     Abstract available
    
    
    
55. SARRAJ A, Campbell BCV, Christensen S, Sitton CW, et al
    Accuracy of CT Perfusion-Based Core Estimation of Follow-Up Infarction: Effects of Time-Since-Last-Known-Well.
    Neurology. 2022 Apr 21. pii: WNL.0000000000200269.
    PubMed     Abstract available
    
    
    
56. SWART G, Balgobind S, Chan C, Fulham M, et al
    Spinal Cord Presentation of Biopsy-Proven PET-Positive Giant Cell Arteritis.
    Neurology. 2022 Apr 15. pii: WNL.0000000000200749.
    PubMed     Abstract available
    
    
    
57. MYERS PS, O'Donnell JL, Jackson JJ, Lessov-Schlaggar CN, et al
    Proteinopathy and Longitudinal Cognitive Decline in Parkinson Disease.
    Neurology. 2022 Apr 13. pii: WNL.0000000000200344.
    PubMed     Abstract available
    
    
    
58. FARRELL ME, Papp KV, Buckley RF, Jacobs HIL, et al
    Association of Emerging beta-Amyloid and Tau Pathology With Early Cognitive Changes in Clinically Normal Older Adults.
    Neurology. 2022;98:e1512-e1524.
    PubMed     Abstract available
    
    
    
59. TIDEMAN P, Stomrud E, Leuzy A, Mattsson-Carlgren N, et al
    Association of beta-Amyloid Accumulation With Executive Function in Adults With Unimpaired Cognition.
    Neurology. 2022;98:e1525-e1533.
    PubMed     Abstract available
    
    
    March 2022
60. JOSEPHS KA, Weigand SD, Whitwell J
    Characterizing Amyloid Positive Individuals With Normal Tau PET Levels After 5 Years: An ADNI Study.
    Neurology. 2022 Mar 21. pii: WNL.0000000000200287.
    PubMed     Abstract available
    
    
    
61. XIE N, Zhou Y
    Clinical Reasoning: Longitudinally Extensive Spinal Cord Lesions in a Middle-aged Man.
    Neurology. 2022;98:419-424.
    PubMed     Abstract available
    
    
    
62. MATSUBARA T, Kameyama M, Tanaka N, Sengoku R, et al
    Autopsy Validation of the Diagnostic Accuracy of (123)I-Metaiodobenzylguanidine Myocardial Scintigraphy for Lewy Body Disease.
    Neurology. 2022 Mar 7. pii: WNL.0000000000200110.
    PubMed     Abstract available
    
    
    February 2022
63. GROBER E, Lipton RB, Sperling RA, Papp KV, et al
    Associations of Stages of Objective Memory Impairment (SOMI) with Amyloid PET and Structural MRI: The A4 Study.
    Neurology. 2022 Feb 23. pii: WNL.0000000000200046.
    PubMed     Abstract available
    
    
    
64. PASCUAL B, Hodics T, Funk Q, Cykowski MD, et al
    Translocator Protein 18 kDa PET Imaging Highlights Asymptomatic Isolated Cerebellar Dysplasia.
    Neurology. 2022 Feb 7. pii: WNL.0000000000200221.
    PubMed    
    
    
    December 2021
65. YOO HS, Jeon S, Cavedo E, Ko M, et al
    Association of beta-Amyloid and Basal Forebrain With Cortical Thickness and Cognition in Alzheimer and Lewy Body Disease Spectra.
    Neurology. 2021 Dec 30. pii: WNL.0000000000013277.
    PubMed     Abstract available
    
    
    
66. LI Y, Schindler SE, Bollinger JG, Ovod V, et al
    Validation of Plasma Amyloid-beta 42/40 for Detecting Alzheimer Disease Amyloid Plaques.
    Neurology. 2021 Dec 14. pii: WNL.0000000000013211.
    PubMed     Abstract available
    
    
    October 2021
67. DELVA A, Michiels L, Koole M, Van Laere K, et al
    Synaptic Damage and Its Clinical Correlates in People With Early Huntington Disease: A PET Study.
    Neurology. 2021 Oct 18. pii: WNL.0000000000012969.
    PubMed     Abstract available
    
    
    
68. MCCABE JJ, Camps-Renom P, Giannotti N, McNulty JP, et al
    Carotid Plaque Inflammation Imaged by PET and Prediction of Recurrent Stroke at 5 Years.
    Neurology. 2021 Oct 5. pii: WNL.0000000000012909.
    PubMed     Abstract available
    
    
    September 2021
69. MILA-ALOMA M, Brinkmalm A, Ashton NJ, Kvartsberg H, et al
    CSF Synaptic Biomarkers in the Preclinical Stage of Alzheimer Disease and Their Association With MRI and PET: A Cross-sectional Study.
    Neurology. 2021 Sep 23. pii: WNL.0000000000012853.
    PubMed     Abstract available
    
    
    
70. SCHINDLER S, Li Y, Buckles VD, Gordon BA, et al
    Predicting Symptom Onset in Sporadic Alzheimer Disease With Amyloid PET.
    Neurology. 2021 Sep 9. pii: WNL.0000000000012775.
    PubMed     Abstract available
    
    
    
71. MCCARTER S, Lesnick TG, Lowe V, Mielke MM, et al
    Cerebral Amyloid Angiopathy Pathology and Its Association With Amyloid-beta PET Signal.
    Neurology. 2021 Sep 9. pii: WNL.0000000000012770.
    PubMed     Abstract available
    
    
    August 2021
72. BEUCLER N
    Reader Response: Scan-Negative Cauda Equina Syndrome: A Prospective Cohort Study.
    Neurology. 2021;97:457.
    PubMed    
    
    
    
73. HOERITZAUER I, Carson A, Statham P, Demetriades A, et al
    Author Response: Scan-Negative Cauda Equina Syndrome: A Prospective Cohort Study.
    Neurology. 2021;97:456-457.
    PubMed    
    
    
    
74. AMELOT A, Planty-Bonjour A, Terrier LM
    Reader Response: Scan-Negative Cauda Equina Syndrome: A Prospective Cohort Study.
    Neurology. 2021;97:455-456.
    PubMed    
    
    
    
75. FRISON E, Proust-Lima C, Mangin JF, Habert MO, et al
    Diabetes Mellitus and Cognition: Pathway Analysis in the MEMENTO Cohort.
    Neurology. 2021;97:e836-e848.
    PubMed     Abstract available
    
    
    July 2021
76. 
    [(11)C]PK11195-PET Brain Imaging of the Mitochondrial Translocator Protein in Mitochondrial Disease.
    Neurology. 2021 Jul 27. pii: WNL.0000000000012559.
    PubMed    
    
    
    
77. WOLTERS EE, Papma JM, Verfaillie SCJ, Visser D, et al
    [18F]Flortaucipir PET Across Various MAPT Mutations in Presymptomatic and Symptomatic Carriers.
    Neurology. 2021 Jul 1. pii: WNL.0000000000012448.
    PubMed     Abstract available
    
    
    June 2021
78. TODISCO M, Zangaglia R, Minafra B, Pisano P, et al
    Clinical Outcome and Striatal Dopaminergic Function After Shunt Surgery in Patients With Idiopathic Normal Pressure Hydrocephalus.
    Neurology. 2021;96:e2861-e2873.
    PubMed     Abstract available
    
    
    
79. BUCIUC M, Duffy JR, Machulda MM, Graff-Radford J, et al
    Clinical, Imaging, and Pathologic Characteristics of Patients With Right Versus Left Hemisphere-Predominant Logopenic Progressive Aphasia.
    Neurology. 2021 Jun 4. pii: WNL.0000000000012322.
    PubMed     Abstract available
    
    
    May 2021
80. SHIN JH, Lee JY, Kim YK, Yoon EJ, et al
    Parkinson Disease-Related Brain Metabolic Patterns and Neurodegeneration in Isolated REM Sleep Behavior Disorder.
    Neurology. 2021 May 19. pii: WNL.0000000000012228.
    PubMed     Abstract available
    
    
    
81. SARACINO D, Ferrieux S, Nogues-Lassiaille M, Houot M, et al
    Primary Progressive Aphasia Associated With GRN Mutations: New Insights Into the Non-amyloid Logopenic Variant.
    Neurology. 2021 May 12. pii: WNL.0000000000012174.
    PubMed     Abstract available
    
    
    
82. MAYBLYUM DV, Becker JA, Jacobs HIL, Buckley RF, et al
    Comparing PET and MRI Biomarkers Predicting Cognitive Decline in Preclinical Alzheimer Disease.
    Neurology. 2021 May 5. pii: WNL.0000000000012108.
    PubMed     Abstract available
    
    
    April 2021
83. BOERWINKLE AH, Wisch JK, Chen CD, Gordon BA, et al
    Temporal Correlation of CSF and Neuroimaging in the Amyloid-Tau-Neurodegeneration Model of Alzheimer Disease.
    Neurology. 2021 Apr 30. pii: WNL.0000000000012123.
    PubMed     Abstract available
    
    
    
84. RIOU A, Houvenaghel JF, Dondaine T, Drapier S, et al
    Functional Role of the Cerebellum in Parkinson Disease: A PET Study.
    Neurology. 2021 Apr 28. pii: WNL.0000000000012036.
    PubMed     Abstract available
    
    
    
85. NASCIMENTO FA, Cochran RL, Chow DZ, Scott JA, et al
    Teaching NeuroImages: Increasing SPECTations for Ictal SPECT in Epilepsy Surgical Evaluation.
    Neurology. 2021 Apr 26. pii: WNL.0000000000012097.
    PubMed    
    
    
    
86. VAN DEN AMEELE J, Hong Y, Manavaki R, Kouli A, et al
    [11C]PK11195-PET Brain Imaging of the Mitochondrial Translocator Protein in Mitochondrial Disease.
    Neurology. 2021 Apr 21. pii: WNL.0000000000012033.
    PubMed     Abstract available
    
    
    
87. ROBERTS G, Durcan Mrcpi R, Donaghy PC, Lawley S, et al
    Accuracy of Cardiac Innervation Scintigraphy for Mild Cognitive Impairment With Lewy Bodies.
    Neurology. 2021 Apr 21. pii: WNL.0000000000012060.
    PubMed     Abstract available
    
    
    
88. SCHOEMAKER D, Charidimou A, Zanon Zotin MC, Raposo N, et al
    Association of Memory Impairment With Concomitant Tau Pathology in Patients With Cerebral Amyloid Angiopathy.
    Neurology. 2021;96:e1975-e1986.
    PubMed     Abstract available
    
    
    March 2021
89. TOPPALA S, Ekblad LL, Tuisku J, Helin S, et al
    Association of Early beta-Amyloid Accumulation and Neuroinflammation Measured With [(11)C]PBR28 in Elderly Individuals Without Dementia.
    Neurology. 2021;96:e1608-e1619.
    PubMed     Abstract available
    
    
    
90. POIRION E, Tonietto M, Lejeune FX, Ricigliano VAG, et al
    Structural and Clinical Correlates of a Periventricular Gradient of Neuroinflammation in Multiple Sclerosis.
    Neurology. 2021 Mar 18. pii: WNL.0000000000011700.
    PubMed     Abstract available
    
    
    
91. BARKHOF BF, Pressman PS
    Time Is of the Essence: Early Detection of Incipient Alzheimer Pathology.
    Neurology. 2021 Mar 2. pii: WNL.0000000000011739.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Nuclear Medicine is free of charge.